Search results (19 results)

Apr 9 2025 by Virginia Gebhart

79 year old male with toxic maculopathy from long term use of Elmiron (15+ yrs.) On exam there is stippled RPE changes, pigment clumping, and subretinal deposits. BCVA 20/100 | 20/40.

Photographer: Virginia Gebhart, Retina Consultants of Carolina

Imaging device: Optos California

Condition/keywords: autofluorescence imaging, cystoid macular degeneration, Elmiron Toxicity, Toxic Maculopathy

Mar 25 2025 by Toolie Winters

Fundus autofluorescence image of a 69-year-old woman with toxic maculopathy OU due to Elmiron usage. Patient stopped using Elmiron in the late 2010s after having been on it for 17 years. The patient has areas of outer retinal and RPE atrophy temporal to fovea that have expanded compared to photos from two years ago. At the time of this appointment, her VA OD was sc20/40-1+2 PH20/30 and VA OS was scCF @ 1 foot.

Photographer: Toolie Winters

Imaging device: Heidelberg Spectralis

Condition/keywords: Elmiron Toxicity, FAF, fundus autofluorescence (FAF), Heidelburg Spectralis, Pentosan Toxicity, Toxic Maculopathy

Nov 27 2024 by Virginia Gebhart

77 year old female with advanced geographic atrophy after years of Elmiron use (stopped in 2018). Serial exams show continued progression of GA. Central vision limited, vision remains stable and patient does not report noticing any changes.

Photographer: Virginia Gebhart, Retina Consultants of Carolina

Imaging device: Optos California

Condition/keywords: geographic atrophy, secondary pigmentary degeneration, toxic maculopathy

Jul 23 2023 by Ahmad B. Tarabishy, MD

62 year old female with rheumatoid arthritis, treated with hydroxychloroquine 200 mg BID for the past 6-8 years. She presents with blurred vision, difficulty reading, and difficulty transitions from dark to light conditions since 4 months.

Photographer: Dr. Angela Rico

Condition/keywords: hydroxychloroquine toxicity, plaquenil toxicity, toxic maculopathy

Jul 23 2023 by Ahmad B. Tarabishy, MD

62 year old female with rheumatoid arthritis, treated with hydroxychloroquine 200 mg BID for the past 6-8 years. She presents with blurred vision, difficulty reading, and difficulty transitions from dark to light conditions since 4 months.

Photographer: Dr. Angela Rico

Condition/keywords: hydroxychloroquine toxicity, plaquenil toxicity, toxic maculopathy

Jul 23 2023 by Ahmad B. Tarabishy, MD

62 year old female with rheumatoid arthritis, treated with hydroxychloroquine 200 mg BID for the past 6-8 years. She presents with blurred vision, difficulty reading, and difficulty transitions from dark to light conditions since 4 months.

Photographer: Dr. Angela Rico

Condition/keywords: hydroxychloroquine toxicity, plaquenil toxicity, toxic maculopathy

Jul 23 2023 by Ahmad B. Tarabishy, MD

62 year old female with rheumatoid arthritis, treated with hydroxychloroquine 200 mg BID for the past 6-8 years. She presents with blurred vision, difficulty reading, and difficulty transitions from dark to light conditions since 4 months.

Photographer: Dr. Angela Rico

Condition/keywords: hydroxychloroquine toxicity, plaquenil toxicity, toxic maculopathy

Jul 23 2023 by Ahmad B. Tarabishy, MD

62 year old female with rheumatoid arthritis, treated with hydroxychloroquine 200 mg BID for the past 6-8 years. She presents with blurred vision, difficulty reading, and difficulty transitions from dark to light conditions since 4 months.

Photographer: Dr. Angela Rico

Condition/keywords: hydroxychloroquine toxicity, plaquenil toxicity, toxic maculopathy

Jul 23 2023 by Ahmad B. Tarabishy, MD

62 year old female with rheumatoid arthritis, treated with hydroxychloroquine 200 mg BID for the past 6-8 years. She presents with blurred vision, difficulty reading, and difficulty transitions from dark to light conditions since 4 months.

Photographer: Dr. Angela Rico

Condition/keywords: hydroxychloroquine toxicity, plaquenil toxicity, toxic maculopathy

Jul 23 2023 by Ahmad B. Tarabishy, MD

62 year old female with rheumatoid arthritis, treated with hydroxychloroquine 200 mg BID for the past 6-8 years. She presents with blurred vision, difficulty reading, and difficulty transitions from dark to light conditions since 4 months.

Photographer: Dr. Angela Rico

Condition/keywords: hydroxychloroquine toxicity, plaquenil toxicity, toxic maculopathy

Jul 23 2023 by Ahmad B. Tarabishy, MD

62 year old female with rheumatoid arthritis, treated with hydroxychloroquine 200 mg BID for the past 6-8 years. She presents with blurred vision, difficulty reading, and difficulty transitions from dark to light conditions since 4 months.

Photographer: Dr. Angela Rico

Condition/keywords: hydroxychloroquine toxicity, plaquenil toxicity, toxic maculopathy

Oct 12 2020 by Elizabeth A Atchison, MD

A 50-year-old woman with a 15 year history of pentosan polysulfate treatment for interstitial cystitis.

Photographer: Amanda McCuen

Imaging device: Clarus 700

Condition/keywords: toxic maculopathy

Oct 12 2020 by Elizabeth A Atchison, MD

A 50-year-old woman with a 15 year history of pentosan polysulfate treatment for interstitial cystitis.

Photographer: Amanda McCuen

Imaging device: Clarus 700

Condition/keywords: toxic maculopathy

Jan 12 2018 by Jessica Norkus

Bilateral ultra-wide field pseudo-color and autofluorescent images of a 46-year-old female with Elmiron Toxicity.

Photographer: Jessica Norkus

Imaging device: Optos

Condition/keywords: autofluorescence imaging, bilateral, color fundus photograph, drug toxicity, Optos, toxic maculopathy, toxic retinopathy, ultra-wide field imaging

Aug 30 2012 by Young Hee Yoon, MD, PhD

Fundus photograph of an 58-year-old woman with a bilateral tamoxifen maculopathy. She had taken tamoxifen for 24 months due to breast cancer. In spite of discontinuation 2 years ago, her macula remained unchanged. Her best-corrected visual acuity was 20/50 in the right and 20/100 in the left.

Photographer: Ji Hee Kim, Asan Medical Center

Imaging device: Canon CR-DGI

Condition/keywords: drug toxicity, toxic maculopathy

Aug 30 2012 by Young Hee Yoon, MD, PhD

Fundus autofluorescence (FAF) of an 58-year-old woman with a bilateral tamoxifen maculopathy. She had taken tamoxifen for 24 months due to breast cancer. In spite of discontinuation 2 years ago, her macula remained unchanged. Her best-corrected visual acuity was 20/50 in the right and 20/100 in the left.

Photographer: Soo Hyun Cho, Asan Medical Center

Imaging device: Heidelberg HRA II

Condition/keywords: drug toxicity, toxic maculopathy

Aug 30 2012 by Young Hee Yoon, MD, PhD

OCT image of an 58-year-old woman with a bilateral tamoxifen maculopathy. She had taken tamoxifen for 24 months due to breast cancer. In spite of discontinuation 2 years ago, her macula remained unchanged. Her best-corrected visual acuity was 20/50 in the right and 20/100 in the left.

Photographer: Soon Tae Kim, Asan Medical Center

Imaging device: Zeiss cirrus HD-OCT 4000

Condition/keywords: drug toxicity, toxic maculopathy

Aug 30 2012 by Young Hee Yoon, MD, PhD

Fundus photograph of an 58-year-old woman with a bilateral tamoxifen maculopathy. She had taken tamoxifen for 24 months due to breast cancer. In spite of discontinuation 2 years ago, her macula remained unchanged. Her best-corrected visual acuity was 20/50 in the right and 20/100 in the left.

Photographer: Sung Hyun Kim, Asan Medical Center

Imaging device: Topcon

Condition/keywords: drug toxicity, toxic maculopathy

Aug 30 2012 by Young Hee Yoon, MD, PhD

Fundus autofluorescence (FAF) of an 58-year-old woman with a bilateral tamoxifen maculopathy. She had taken tamoxifen for 24 months due to breast cancer. In spite of discontinuation 2 years ago, her macula remained unchanged. Her best-corrected visual acuity was 20/50 in the right and 20/100 in the left.

Photographer: Kyoung Woon Kim, Asan Medical Center

Imaging device: Heidelberg

Condition/keywords: drug toxicity, toxic maculopathy